Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)
Funding Opportunity PAR-18-802 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the US. Specifically, the FOA solicits encourages grant applications from SBCs to develop or adapt, apply, and validate existing or emerging technologies into user-friendly product...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 24, 2018 Category: Research Source Type: funding

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)
Funding Opportunity PAR-18-801 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the US. Specifically, the FOA solicits encourages grant applications from SBCs to develop or adapt, apply, and validate existing or emerging technologies into user-friendly product...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 24, 2018 Category: Research Source Type: funding

Request for Proposals (RFP) N01CN77019-18 "PREVENT Cancer Preclinical Drug Development Program"
Notice NOT-CA-18-073 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 16, 2018 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for the Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54)
Notice NOT-CA-18-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 14, 2018 Category: Research Source Type: funding

Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
Grants for observational and intervention research projects designed to reduce the burden of cancer and improve the quality of cancer care in rural areas among low-income and/or underserved populations. Geographic coverage: Nationwide -- National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 2, 2018 Category: American Health Source Type: funding

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)
Funding Opportunity PAR-18-767 from the NIH Guide for Grants and Contracts. Partnerships to Advance Cancer Health Equity (CPACHE) Program. The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity population and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a stronger national cancer program and address challenges in cancer and cancer disparities research, education and outreach, as well as their impact on underserved populations. The institutions in each partne...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2018 Category: Research Source Type: funding

Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
Funding Opportunity RFA-CA-18-026 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to reduce the burden of cancer and improve the quality of cancer care in rural areas among low-income and/or underserved populations. The FOA encourages two types of applications: 1) observational research that includes pilot testing of intervention to understand and address predictors of cancer care/treatment and outcomes in rural low-income and/or underserved populations, or 2) intervention research to address known predictors of cancer care/treatment and outcomes in rural low-inco...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2018 Category: Research Source Type: funding

Cancer research and global health initiative
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - April 23, 2018 Category: Research Source Type: funding

Notice of Correction to Award Information in PAR-18-246 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)"
Notice NOT-CA-18-064 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 23, 2018 Category: Research Source Type: funding

Notice of Correction to Award Information in PAR-18-247 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)"
Notice NOT-CA-18-065 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 23, 2018 Category: Research Source Type: funding

Presolicitation Notice: Request for Proposals (RFP) N01CN77019-18 "PREVENT Cancer Preclinical Drug Development Program: Preclinical Services for Biopharmaceutical Product Development and Manufacturing, Toxicology and Pharmacology Testing"
Notice NOT-CA-18-070 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 23, 2018 Category: Research Source Type: funding

Notice of Change in Eligible Organizations in PA-18-748 Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed)" to Allow Foreign Institutions.
Notice NOT-CA-18-069 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 23, 2018 Category: Research Source Type: funding

Cancer research and global health initiative
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - April 23, 2018 Category: Research Source Type: funding

National Cancer Institute (NCI) Request for Information (RFI): Strategies for Matching Patients to Clinical Trials
Notice NOT-CA-18-063 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 11, 2018 Category: Research Source Type: funding

Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed)
Funding Opportunity PAR-18-752 from the NIH Guide for Grants and Contracts. This administrative supplement funding opportunity announcement (FOA) from the National Cancer Institute (NCI) is part of the Cancer Moonshot initiative to accelerate cancer research, and was developed in response to a recommendation from the Blue Ribbon Panel of experts charged with advising the National Cancer Advisory Board on exceptional scientific opportunities that could be accelerated through this initiative. As part of the Cancer Moonshot initiative, the NCI created the Drug Resistance and Sensitivity Network (DRSN), a collaborative networ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 11, 2018 Category: Research Source Type: funding

Request for Information (RFI): Nomination of Molecular Targets Substantially Relevant to the Growth or Progression of Pediatric Cancers
Notice NOT-CA-18-062 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 10, 2018 Category: Research Source Type: funding

Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed)
Funding Opportunity PA-18-748 from the NIH Guide for Grants and Contracts. The purpose of the administrative supplement is to provide support for NIH-funded investigators to prepare and deposit individual-level data from cancer epidemiology studies into NIH/NCI-supported, controlled-access databases including the Cancer Epidemiology Data Repository (CEDR) and the database of Genotypes and Phenotypes (dbGaP). Sharing of research data will accelerate scientific discovery and increase opportunities for collaboration to provide new clues to cancer etiology, determine risk factors, and improve cancer survivorship. (Source: NIH...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 10, 2018 Category: Research Source Type: funding

Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators with active NCI R01 research grants. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-18-019 (R01) and RFA-CA-18-020 (R21) . This FOA encourages research that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care. St...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2018 Category: Research Source Type: funding

Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators with active NCI U01 research grants. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-18-019 (R01) and RFA-CA-18-020 (R21) . This FOA encourages research that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care. St...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2018 Category: Research Source Type: funding

Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators with active NCI P50 research grants. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-18-019 (R01) and RFA-CA-18-020 (R21) . This FOA encourages research that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care. St...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2018 Category: Research Source Type: funding

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-023 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators with active NCI P01 research grants. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-18-019 (R01) and RFA-CA-18-020 (R21) . This FOA encourages research that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care. St...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2018 Category: Research Source Type: funding

NCI Announcement of Interest in Supporting Immuno-Oncology Research and Career Development through NIH Parent PA-18-591, "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
Notice NOT-CA-18-056 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2018 Category: Research Source Type: funding

Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-733 from the NIH Guide for Grants and Contracts. The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotype data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects. The overall goal of the Gabriella Miller Kids First Pediatric Data Resource is to help researchers understand the underlying mechanisms of these conditions, leading to more refined diagnostic capabilities and u...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 30, 2018 Category: Research Source Type: funding

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-731 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to enhance the diversity of the pool of NCI-funded research workforce by recruiting and supporting eligible investigators from groups that have been shown to be nationally underrepresented in the biomedical, behavioral, clinical and social sciences. This funding opportunity will also provide a bridge to investigators who have completed their research training and may need extra time to develop a larger research project grant application. (Source: NIH Funding ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 29, 2018 Category: Research Source Type: funding

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01)
Research grants that address patient adherence to treatment and prevention regimens to promote positive health outcomes. Clinical trials are optional. Geographic coverage: Nationwide -- National Cancer Institute, National Center for Complementary and Integrative Health, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute of Nursing Research, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of ...
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - March 28, 2018 Category: Infectious Diseases Source Type: funding

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 and R21 Clinical Trial Optional)
Research grants that address patient adherence to treatment and prevention regimens to promote positive health outcomes. Clinical trials are optional. Geographic coverage: Nationwide -- National Cancer Institute, National Institute of Mental Health, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 28, 2018 Category: American Health Source Type: funding

Notice of Change in Eligible Organizations in PA-18-629 Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)" to Allow Foreign Components in Domestic Applications
Notice NOT-CA-18-059 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 26, 2018 Category: Research Source Type: funding

Notice of Information for PA-18-529, " Early-life Factors and Cancer Development Later in Life (R01 Clinical Trial Not Allowed)"
Notice NOT-CA-18-058 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 26, 2018 Category: Research Source Type: funding

Notice of Correction to the Specific Research Objectives for PA-16-175 Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)"
Notice NOT-CA-18-057 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 19, 2018 Category: Research Source Type: funding

Notice of Change to PAR-17-233 "Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)"
Notice NOT-CA-18-055 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 19, 2018 Category: Research Source Type: funding

Iowa Care for Yourself - Breast and Cervical Cancer Screening Services
Provides grants to local boards of health in Iowa to provide outreach, program enrollment, breast and cervical cancer screenings/diagnostic services, data reporting, and patient navigation services for eligible patients. Geographic coverage: Iowa -- Iowa Department of Public Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 16, 2018 Category: American Health Source Type: funding

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have no...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 9, 2018 Category: Research Source Type: funding

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have no...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 9, 2018 Category: Research Source Type: funding

Tribal Health Systems Enhancement for Cancer Screening
Funding to pilot test a toolkit developed by NIHB with a focus on increasing high-quality, population-based breast, cervical, and colorectal cancer screenings. Geographic coverage: Nationwide -- National Indian Health Board (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 8, 2018 Category: American Health Source Type: funding

Notice of NIBIB's Participation in PAR-17-093 "Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01)"
Notice NOT-EB-18-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 7, 2018 Category: Research Source Type: funding

FY 2017 By the Numbers
We recently released our annual web reports, success rates and NIH Data Book with updated numbers for fiscal year 2017. Looking at data across both competing and non-competing awards, NIH supports approximately 2,500 organizations.  In 2017 about 640 of these organizations received funding for competing Research Project Grants (RPGs) which involved over 11,000 principal investigators. The average size of RPGs increased by over 4%, from $499,221 in FY 2016 to $520,429 in FY 2017. Similarly, in FY 2017 the average size of R01-equivalent awards increased from $458,287 to $482,395 (by ov...
Source: NIH Extramural Nexus - March 7, 2018 Category: Research Authors: Mike Lauer Tags: blog Open Mike Award rate Funding data R01 Success Rate Source Type: funding

Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-704 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research projects focused on adducts to cellular macromolecules as indicators of exposures to cancer risk factors relevant to human populations. The priority is on projects that will focus on adductomic approaches, i.e., address some aspects of the totality of adducts. These projects should explore the basic aspects of adducts/adductomics that may have a potential utility in cancer detection, cancer prevention, and/or assessing cancer risks. The projects should be relevant to adducts in humans...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2018 Category: Research Source Type: funding

Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-703 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research projects focused on adducts to cellular macromolecules as indicators of exposures to cancer risk factors relevant to human populations. The priority is on projects that will focus on adductomic approaches, i.e., address some aspects of the totality of adducts. These projects should explore the basic aspects of adducts/adductomics that may have a potential utility in cancer detection, cancer prevention, and/or assessing cancer risks. The projects should be relevant to adducts in humans...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2018 Category: Research Source Type: funding

Notice of Correction to RFA-CA-18-010, "Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)"
Notice NOT-CA-18-036 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 2, 2018 Category: Research Source Type: funding

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-681 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage projects to generate fundamental knowledge of affective processes. Basic affective science projects should have key consequences for single (e.g., cancer screening) and multiple (e.g., adherence to oral chemotherapy regimen) event decisions and behaviors across the cancer prevention and control continuum. The FOA is expected to encourage collaboration among cancer control researchers and those from scientific disciplines not traditionally connected to cancer control applica...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 27, 2018 Category: Research Source Type: funding

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-678 from the NIH Guide for Grants and Contracts. The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2018 Category: Research Source Type: funding

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-677 from the NIH Guide for Grants and Contracts. The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2018 Category: Research Source Type: funding

U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-674 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use cancer health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. The long-term goal of this FOA is t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2018 Category: Research Source Type: funding

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-675 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use cancer health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. The long-term goal of this FOA is t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2018 Category: Research Source Type: funding

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cance...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2018 Category: Research Source Type: funding

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-17-020 from the NIH Guide for Grants and Contracts. Type 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomateria...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2018 Category: Research Source Type: funding

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Type 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomaterials engineering, are especially encouraged.Lisa Spain, Ph.D. | RFA-DK-17-020 (Sou...
Source: NIDDK Funding Opportunities - February 14, 2018 Category: Endocrinology Source Type: funding

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-655 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2018 Category: Research Source Type: funding

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
Funding Opportunity PAR-18-654 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2018 Category: Research Source Type: funding